Bone Biologics Corp BBLG

Healthcare Biotechnology

Bone Biologics Corporation is a medical device company. The Company is focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. The NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. The NELL-1/DBM Fusion Device offers a range of procedures, including Spine Implants, Non-Union Trauma Cases and Osteoporosis. The NELL-1 is a function specific recombinant human protein that has been proven in laboratory bench models to recapitulate normal human growth and development to provide control over bone and cartilage regeneration. The Company develops platform technology through significant laboratories and small and large animal research to generate applications across fields of use. The platform technology is its recombinant human protein, known as NELL-1, a skeletal specific growth factor which is a bone void filler.

NDAQ:BBLG - Post by User

Bone Biologics Corp

Bullboard Posts

Next >>

Post by whytestockson Jun 06, 2023 7:30pm

42 Views

Post# 35483439

Bone Biologics Effects 1-for-30 Reverse Stock Split

JUST IN: $BBLG Bone Biologics Effects 1-for-30 Reverse Stock SplitBone Biologics Corporation (NASDAQ: BBLG) , a developer of orthobiologic products for spine fusion markets, announces that a 1-for-30 reverse stock split became effective on June 5, 2023 and that its common stock and warrants will begin trading on a split-adjusted basis with the open of the m...BBLG - Bone Biologics Effects 1-for-30 Reverse Stock Split

Bullboard Posts

Next >>

Critical raw materials pioneer drives Europe’s clean energy transition